As microbiological tests play an important role in our diagnostic algorithms and clinical
approach towards patients at-risk for pulmonary aspergillosis, a good knowledge of the …

Background Efficient diagnosis of patients at high risk for invasive aspergillosis (IA)
improves the outcome of the disease. Lateral flow assay (LFA) is a novel technology and …

Based on established clinical performance few mycological tests can be used alone for
optimal diagnosis of fungal disease (FD) and combining tests, including classical …

Introduction During the Omicron pandemic in China, a significant proportion of patients with
Coronavirus Disease 2019 (COVID-19) associated pulmonary aspergillosis (CAPA) …

Background Bronchoalveolar lavage (BAL) galactomannan (GM) is commonly used to
diagnose Aspergillus‐related lung diseases. However, unlike serum GM, which is measured …

Lipopolysaccharides (LPSs) are major components of the outer membranes of Gram-
negative bacteria. In this work, the structure of the O-polysaccharide of Ochrobactrum …

Chronic pulmonary aspergillosis (CPA) is a challenging respiratory infection caused by the
environmental fungus Aspergillus. CPA has a poor prognosis, with reported 1-year mortality …

Background The morbidity and mortality of chronic pulmonary aspergillosis (CPA) are very
high. We aimed to investigate the prognostic factors of patients with CPA, especially …

Chronic pulmonary aspergillosis (CPA) encompasses all disease manifestations caused by
Aspergillus in the lung that do not include invasive or allergic disease. It can range from a …

A pulmonary Aspergillus nodule is a rare subtype of chronic pulmonary aspergillosis. The
diagnosis is difficult and is histological. There are only a few reports on such cases. Here …